D-0812-2016 Class III Terminated
FDA drug recall D-0812-2016 was initiated by Jubilant Draximage Inc on Mar 11, 2016 and is designated Class III. Reason for recall: Labeling: Label Error on Declared Strength The recall status is terminated (terminated Aug 7, 2017). Affected quantity: 90 vials (450 capsules).
Recall details
- Product Type
- Drugs
- Report Date
- Apr 13, 2016
- Initiation Date
- Mar 11, 2016
- Termination Date
- Aug 7, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 90 vials (450 capsules)
Product description
SODIUM IODIDE I 131 CAPSULE, USP DIAGNOSTIC ORAL , Rx only, Manufactured by Jubilant DraxImage, Inc., Kirkland, QC, Canada, NDC 65174-461-05
Reason for recall
Labeling: Label Error on Declared Strength
Distribution pattern
Nationwide
Code information
Lot Number 1670123; Exp 04/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0812-2016
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026